TAKI CHEMICAL (4025) FY2026 Q2 Earnings Report

Quick View

Executive Summary

Operating income growth exceeded the double-digit increase in revenue, resulting in a strong earnings performance with improved margins. Revenue was ¥234.9B (+12.0% YoY), operating income was ¥22.6B (+32.6%), ordinary income was ¥26.2B (+30.6%), and net income was ¥18.8B (+34.5%). Operating leverage driven by gross profit expansion and the relative containment of SG&A expenses enabled profit growth to exceed revenue growth. Progress toward the full-year forecast was 65.4% for operating income and 64.0% for ordinary income, both above the standard 50% benchmark, while revenue progress was limited to 51.9%; maintaining margins in the second half will be key to the full-year assessment.

Factors Affecting Earnings

【Revenue】Revenue was ¥234.9B, representing a +12.0% increase YoY. It is progressing at a pace exceeding the full-year company forecast of +7.9% revenue growth, suggesting that the demand environment was relatively strong in the first half.

【Profitability】Operating income was ¥22.6B (+32.6% YoY), and the operating margin improved to 9.6% from approximately 8.1% in the same period of the previous year, an improvement of approximately 1.5pt. Against a gross margin of 25.6%, the SG&A ratio was 15.9%, indicating that although part of the revenue increase was absorbed by SG&A expenses, a sufficient level of profit conversion was achieved. Ordinary income of ¥26.2B exceeded operating income, primarily due to ¥3.8B in non-operating income, including ¥3.4B in dividend income; therefore, core operating profitability should be evaluated based on operating income. Extraordinary gains and losses comprised a gain of ¥0.1B and a loss of ¥0.2B, respectively, and were immaterial on a net basis, with only a limited temporary impact on net income of ¥18.8B. In conclusion, the Company achieved both revenue and profit growth.

Key Financial Indicators

【Profitability】The operating margin of 9.6% and net profit margin of 8.0% both improved from the same period of the previous year (approximately 8.1% for the operating margin and approximately 6.7% for the net profit margin). The EBITDA margin was equivalent to 12.6%, with operating leverage accompanying revenue growth pushing up margins. 【Cash Flow Quality】Operating cash flow (OCF) was ¥21.1B, or 1.13 times net income of ¥18.8B, indicating good cash conversion of earnings; however, the OCF/EBITDA ratio remained at 0.71x, indicating that working capital requirements remain a burden relative to EBITDA. 【Investment Efficiency】ROE was 4.0%. Investment securities accounted for ¥214.9B, or 30.4% of total assets of ¥706.4B, suppressing asset turnover and weighing on ROE. 【Financial Soundness】The equity ratio was 67.2%, interest-bearing debt was limited, and the Company maintained ample short-term liquidity, with current assets of ¥309.2B compared with current liabilities of ¥107.4B.

Cash Flow Analysis

Operating cash flow was positive at ¥21.1B, representing a significant improvement from the vicinity of zero in the same period of the previous year. Investing cash flow was negative ¥5.0B, consisting primarily of expenditures for the acquisition of fixed assets, while financing cash flow was negative ¥7.0B, mainly due to dividend payments of ¥6.3B. As a result, free cash flow was positive at ¥16.0B, demonstrating that operating activities generated sufficient funds to cover both investment and dividends. However, against operating cash flow subtotal of ¥23.2B, the ¥12.8B increase in trade receivables and ¥8.1B decrease in trade payables placed pressure on cash flow. The expansion of working capital accompanying revenue growth will be a factor influencing future cash conversion efficiency. Cash and cash equivalents at period-end accumulated to ¥81.6B, indicating a high level of financial flexibility.

Earnings Quality

Operating income of ¥22.6B was the core source of earnings, while the difference from ordinary income of ¥26.2B was attributable primarily to non-operating income, including ¥3.4B in dividend income. This represents stable income from the investment portfolio but should be distinguished from core business earnings. Extraordinary gain of ¥0.1B and extraordinary loss of ¥0.2B were immaterial on a net basis, and net income of ¥18.8B had limited dependence on temporary factors. Operating cash flow remained at 1.13 times net income, exceeding net income, and there were limited signs that accounting profit depended excessively on accrued income; however, the increase in trade receivables indicates delayed cash conversion from a working capital perspective. Comprehensive income was ¥47.5B, substantially exceeding net income, primarily due to ¥28.9B in valuation differences on other securities. It therefore needs to be evaluated separately from the Company’s business earning power.

Earnings Forecast and Guidance

The full-year company forecasts are revenue of ¥453.0B (+7.9%), operating income of ¥34.5B (+9.0%), and ordinary income of ¥41.0B (+8.5%). Based on first-half results, progress rates were 51.9% for revenue, 65.4% for operating income, 64.0% for ordinary income, and 53.4% for net income. At the operating level, progress exceeded the standard 50% benchmark by more than 10pt. Since revenue progress remained broadly at a standard level, the extent to which the Company can maintain its high margins in the second half will determine the degree of full-year achievement. The Company revised both its earnings forecast and dividend forecast, suggesting that the revisions were made in an upward direction.

Shareholder Returns

The forecast annual dividend for the fiscal year ending December 2026 is ¥105 per share, representing an increase from the total of ¥75, comprising the previous fiscal year’s ordinary dividend of ¥60, a ¥5 dividend commemorating the Company’s 140th anniversary, and a ¥10 special dividend. Based on the company forecast EPS of ¥419.57, the forecast payout ratio is 25.0%; free cash flow of ¥16.0B provided approximately 2.6x coverage of dividend payments of ¥6.3B for the current period. There is no disclosure regarding share repurchases, and shareholder returns are centered on dividends. Given the low level of interest-bearing debt and ample liquidity, the forecast dividend level is considered financially sustainable.

Risk Factors

1. Extension of the collection period for trade receivables: Trade receivables, including accounts receivable and notes receivable of ¥123.6B, increased by ¥12.8B from the previous year, suggesting an extension of DSO. If this trend continues during a period of revenue growth, operating cash flow growth may be restrained relative to earnings growth.

2. Raw material and energy costs and price pass-through: As a chemical manufacturer, increases in input costs or delays in passing such increases through to selling prices could affect the sustainability of the operating margin, which has currently improved to 9.6%.

3. Market fluctuation risk associated with securities holdings: Investment securities of ¥214.9B account for 30.4% of total assets and affect both ordinary income (¥3.4B in dividend income) and comprehensive income (¥28.9B in valuation differences). Changes in market prices may cause fluctuations in net assets and earnings levels.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The operating margin is broadly in line with the industry median, while the net profit margin exceeds the industry median, supported by an earnings structure that includes non-operating income.

Growth and Capital Efficiency

Revenue growth is slightly above the industry median, indicating a solid revenue growth phase relative to the industry.

※Source: Compiled by the Company

Key Earnings Highlights

1. Revenue increased 12.0%, while operating income increased 32.6%, and the operating margin improved by approximately 1.5pt from the same period of the previous year. Profit growth exceeding revenue growth demonstrates the effect of operating leverage resulting from gross profit expansion and SG&A absorption.

2. Progress rates for operating income and ordinary income against the full-year forecasts both exceeded 64%, above the standard progress rate, while revenue progress remained around 52%. This indicates that the trend in margins in the second half will determine the full-year outcome.

3. The OCF/EBITDA ratio remained at 0.71x against the backdrop of an increase in trade receivables. The expansion of working capital requirements accompanying revenue growth will be a key point to monitor in assessing cash conversion efficiency relative to earnings growth.

Theoretical Share Price (Reference Value)

Sensitivity: ¥5,245–¥5,553 at ±1% for the cost of equity, and ¥5,385–¥5,402 at ±0.1 for ω.

Notes:

• Goodwill amortization of ¥1.0 per share has been added back to earnings (as a non-cash expense and for comparability with IFRS companies).
• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end have been used (there is a time lag relative to the full-year forecast).
• Since net assets include non-controlling interests, the theoretical value may be calculated at a somewhat high level.

(Calculation model: Residual income model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 was a strong first-half result for 多木化学, with revenue growth translating into materially faster operating and net-profit growth. Revenue rose 12.0% year on year to ¥23.49bn. Operating income increased 32.6% to ¥2.26bn, exceeding the pace of sales growth by a wide margin. Ordinary income rose 30.6% to ¥2.62bn. Profit attributable to owners of the parent increased 33.5% to ¥1.87bn. The gross margin improved to 25.6% from 24.5% a year earlier, an expansion of roughly 110bp. The operating margin improved to 9.6% from 8.1%, an expansion of roughly 150bp. Net margin rose to 8.0% from 6.7%, also improving by roughly 130bp. The margin progression indicates favorable operating leverage, as SG&A increased 9.2%, slower than the 12.0% revenue increase. Non-operating income of ¥0.38bn was largely supported by ¥0.34bn of dividend income, which augmented ordinary income but does not detract from the underlying operating-profit improvement. Operating cash flow was ¥2.11bn and exceeded net income of ¥1.87bn, producing an OCF/net income ratio of 1.13x and supporting earnings quality. Free cash flow was positive at ¥1.60bn after ¥0.50bn of investing outflow. The balance sheet remains exceptionally liquid, with a 288.0% current ratio, ¥8.17bn of cash, and only ¥0.81bn of interest-bearing debt. Annualized ROE was 7.9%, supported principally by the 8.0% net margin and 0.665x annualized asset turnover, while modest 1.49x financial leverage limits balance-sheet-driven returns. The principal operating watchpoint is the quality and pace of receivable collection, with a quality alert for 96 annualized DSO, despite robust headline liquidity. Full-year guidance implies that first-half revenue has reached 51.9% of the annual forecast, while operating income has already reached 65.4%, leaving scope for upside if first-half profitability persists, although seasonality and the revised forecast need to be considered. The proposed FY2026 ordinary year-end dividend of ¥105 per share implies a conservative 25.0% payout ratio against forecast EPS of ¥419.57, indicating substantial earnings and cash-flow coverage.

Profitability Analysis

Annualized DuPont ROE is 7.9%, decomposed into an 8.0% net profit margin, 0.665x annualized asset turnover, and 1.49x financial leverage. The largest positive change evident in the P&L is margin expansion: operating margin increased by about 150bp year on year to 9.6%, compared with a roughly 110bp improvement in gross margin. This indicates that the earnings acceleration was driven both by improved gross profitability and by operating leverage, as SG&A grew 9.2%, below revenue growth of 12.0%. Gross profit increased 16.9% to ¥6.00bn, while SG&A increased ¥0.32bn to ¥3.74bn, enabling operating income to rise ¥0.56bn to ¥2.26bn. EBITDA increased to ¥2.96bn and the EBITDA margin reached 12.6%, providing a cash-oriented measure of the improved operating performance. The tax burden was 0.715, equivalent to a 28.0% effective tax rate, which is within a normal range and did not materially dilute profitability. The interest burden was 1.158 because non-operating income exceeded the very small interest expense; interest expense was only ¥0.01bn, and interest coverage was an exceptionally high 250.78x. Dividend income of ¥0.34bn represented 14.3% of operating income and accounted for most non-operating income, so ordinary-income growth includes a meaningful investment-income contribution. However, the core operating result itself was strong, with operating income growth of 32.6% exceeding ordinary-income growth of 30.6%. Extraordinary items were immaterial: ¥0.09bn of extraordinary income and ¥0.20bn of extraordinary loss resulted in a limited net negative effect. JGAAP goodwill amortization was only ¥0.004bn, or about 0.1% of EBITDA, so JGAAP-versus-IFRS goodwill accounting has no material effect on comparative profitability. The 7.9% annualized ROE is near the stated 8% threshold but remains below a 10%-plus level generally associated with stronger capital efficiency. The relatively low financial leverage means that future ROE improvement will need to come mainly from sustainable margin gains, faster asset utilization, or capital allocation rather than debt-financed expansion.

Growth Assessment

Revenue growth of 12.0% to ¥23.49bn demonstrates solid first-half demand and/or pricing momentum. Operating income growth of 32.6% materially outpaced sales growth, indicating positive operating leverage rather than purely volume-led expansion. The gross-profit increase of ¥0.87bn exceeded the ¥0.32bn increase in SG&A, which was the direct mechanism behind the ¥0.56bn operating-income increase. Finished goods were ¥4.04bn, down 15.5% year on year, which is consistent with inventory absorption rather than an accumulation of completed-product stock. Full-year revenue guidance is ¥45.30bn, up 7.9% year on year, and Q2 cumulative revenue represents 51.9% of that forecast, modestly above the standard 50% first-half progress rate. Full-year operating-income guidance is ¥3.45bn, up 9.0% year on year, and first-half progress is 65.4%, 15.4 percentage points above the standard 50% pace. Ordinary-income progress is 64.0% against the ¥4.10bn forecast, also 14.0 percentage points above the standard pace. Profit attributable to owners has reached 53.4% of the ¥3.50bn full-year forecast, only moderately ahead of a standard first-half pace. The greater first-half progress in operating profit than in net income reflects the normal effects of tax and non-operating-item composition rather than a deterioration in the core business. Management has revised both earnings and dividend forecasts; the retained full-year targets should therefore be assessed against the degree to which first-half margins normalize in the second half. Investment securities totaled ¥21.49bn, equivalent to 30.4% of total assets, and dividend income from these holdings was a relevant contributor to ordinary income. This investment-income contribution can support earnings but introduces sensitivity to portfolio dividend policies and market valuations. For a chemical manufacturer, sustainability of the first-half margin gains will depend on input-cost conditions, pricing discipline, production efficiency, and demand across end markets.

Financial Health

Financial health is very strong. Current assets of ¥30.93bn were 2.88 times current liabilities of ¥10.74bn, resulting in a 288.0% current ratio. The 250.5% quick ratio confirms that liquidity does not depend on inventory monetization. Working capital was a substantial ¥20.19bn. Cash and deposits were ¥8.17bn, compared with short-term loans of ¥0.48bn, yielding cash coverage of 16.89x for short-term debt. Interest-bearing debt was only ¥0.81bn, equal to 1.7% of capital and 0.27x EBITDA. Debt/EBITDA and both EBIT- and EBITDA-based interest-coverage metrics indicate negligible debt-servicing pressure. The reported debt-to-equity ratio is 0.49x, while interest-bearing debt is only about 1.7% of total equity; in either presentation, leverage is conservative and far below the 2.0x high-leverage warning threshold. Total equity increased ¥4.16bn year on year to ¥47.49bn, and the equity ratio improved to 66.6% from 65.3%. A substantial portion of the balance sheet is represented by investment securities at ¥21.49bn, creating exposure to equity-market valuation movements; valuation gains drove ¥2.89bn of OCI in the period. Deferred tax liabilities increased to ¥5.50bn from ¥4.14bn, consistent with the larger unrealized-gain reserve associated with securities holdings. The quality alert on a 60.0% short-term debt ratio warrants attention because a large proportion of the small debt balance matures within one year. However, refinancing risk is low in practical liquidity terms because cash is 16.89 times short-term debt, the current ratio is 288.0%, and debt/EBITDA is only 0.27x. Lease obligations and defined-benefit liabilities are the relevant non-bank obligations, including a ¥3.37bn net defined-benefit liability, but they do not compromise current liquidity given the capital base and operating cash generation.

Notable B/S Changes

Investment securities: +¥4.26bn (+24.7%) to ¥21.49bn - portfolio growth and/or valuation appreciation increased financial-market sensitivity; securities represent 30.4% of total assets. Deferred tax liabilities: +¥1.36bn (+32.9%) to ¥5.50bn - consistent with increased unrealized gains, linking future balance-sheet movements to securities valuations. Accumulated other comprehensive income: +¥2.87bn (+28.6%) to ¥12.90bn - primarily reflects the ¥2.89bn valuation gain on securities recognized in OCI, strengthening reported equity but increasing market-value dependence. Total equity: +¥4.16bn (+9.6%) to ¥47.49bn - driven by retained earnings and OCI gains, lifting the equity ratio to 66.6% from 65.3%.

Cash Flow Quality

Cash-flow quality improved materially. Operating cash flow was ¥2.11bn, versus profit attributable to owners of ¥1.87bn, resulting in a healthy 1.13x OCF/net income ratio. This is above the 1.0x benchmark and does not indicate an accrual-led earnings profile. The accruals ratio was -0.3%, also consistent with high-quality earnings conversion. EBITDA was ¥2.96bn, and cash conversion of OCF/EBITDA was 0.71x. This is slightly above the 0.70x concern threshold but below the 0.9x level associated with excellent conversion, so working-capital discipline remains important. Operating cash flow was supported by an inventory-related cash inflow of ¥0.71bn. Conversely, trade receivables increased by ¥1.28bn, creating a material use of cash and aligning with the quality alert for 96 annualized receivable days. The high DSO is the central working-capital risk: it can delay conversion of reported revenue into cash and may raise exposure to customer credit conditions. The alert is particularly relevant for a manufacturing business, where receivable collection must fund materials procurement and production cycles. Trade payables declined by ¥0.81bn, which also reduced operating cash flow and indicates less supplier-financing support than in the prior period. Investing cash outflow was ¥0.50bn, including ¥0.44bn of purchases of non-current assets. Free cash flow was therefore positive at ¥1.60bn. Financing cash flow was negative ¥0.70bn, primarily reflecting ¥0.63bn of cash dividends paid, while debt movements were immaterial. Cash increased by ¥0.91bn during the first half to ¥8.16bn in cash and cash equivalents. Positive free cash flow, a low accruals ratio, and OCF above net income provide a solid base, but future cash conversion should be monitored through receivable days and any reversal of the inventory-related cash benefit.

Dividend Sustainability

The forecast FY2026 year-end ordinary dividend is ¥105 per share. Based on forecast EPS of ¥419.57, the implied dividend payout ratio is approximately 25.0%. This is well below the 60% sustainability benchmark and leaves a substantial earnings retention buffer. The FY2025 year-end dividend included a ¥60 ordinary dividend, a ¥5 140th-anniversary commemorative dividend, and a ¥10 special dividend, for total DPS of ¥75. The move to a ¥105 ordinary dividend therefore represents a stronger recurring shareholder-return commitment rather than reliance on a commemorative or special distribution. First-half cash dividends paid were ¥0.63bn, while free cash flow was ¥1.60bn, implying 2.6x FCF coverage of paid dividends. Operating cash flow of ¥2.11bn also covered the paid dividend by 3.4x. The company holds ¥8.17bn in cash and has only ¥0.81bn of interest-bearing debt, providing ample balance-sheet flexibility for the projected distribution. Retained earnings were ¥32.37bn, supporting dividend capacity. No share-buyback cash flow is identified in the period, so the dividend payout ratio is the appropriate shareholder-return measure. The sustainability case depends primarily on preserving operating margins and converting receivables into cash, rather than on access to external financing. The investment-securities portfolio and associated dividend income provide supplementary support to ordinary earnings, although such income should not be treated as fully equivalent to operating cash generation. Overall, the planned ¥105 DPS appears conservatively covered by forecast earnings, current free cash flow, and net cash resources.

Risk Assessment

Business risks include Receivable-collection risk is elevated: the 96-day annualized DSO quality alert is well above the 60-day warning level. Higher receivables absorb cash, increase customer-credit exposure, and could weaken cash conversion if collection periods extend further., Chemical-manufacturing margins remain exposed to raw-material, energy, logistics, and environmental-compliance cost volatility. The first-half operating-margin expansion to 9.6% is favorable, but sustaining it requires pricing and procurement discipline., Demand cyclicality across industrial and agricultural-related end markets could affect volumes, utilization, and pricing, particularly if the strong first-half operating-profit run rate normalizes in the second half., Investment securities of ¥21.49bn, equal to 30.4% of total assets, create exposure to equity-market movements and investee dividend policies. The ¥2.89bn securities valuation gain recorded in OCI highlights the materiality of market-value fluctuations..

Financial risks include The 60.0% short-term debt ratio triggers the refinancing-risk quality alert because most debt is short maturity. The practical impact is currently low, however, given ¥8.17bn of cash, 16.89x cash coverage of short-term debt, and only 0.27x debt/EBITDA., Deferred tax liabilities of ¥5.50bn are significant and increased 32.9% year on year, reflecting unrealized gains and reinforcing the link between equity and financial-market valuations., The ¥3.37bn net defined-benefit liability is a longer-term obligation that may be sensitive to discount rates and asset returns, although it is manageable relative to ¥47.49bn of equity..

Key concerns include Priority one is whether receivable days decline from the 96-day annualized level; this is the principal risk to otherwise strong operating cash conversion., Priority two is the durability of the first-half 150bp operating-margin expansion, especially as operating-income progress is already 65.4% of full-year guidance., Priority three is valuation and income concentration associated with the large investment-securities portfolio, which can affect OCI, net assets, and non-operating dividend income., Priority four is maintaining adequate renewal and productivity investment in manufacturing assets while preserving positive free cash flow..

Investment Implications

Key takeaways include First-half revenue grew 12.0%, while operating income and profit attributable to owners grew 32.6% and 33.5%, respectively, demonstrating strong operating leverage., Gross margin expanded about 110bp to 25.6% and operating margin expanded about 150bp to 9.6%., Earnings quality is favorable: OCF was ¥2.11bn, 1.13x profit attributable to owners, and free cash flow was positive at ¥1.60bn., The balance sheet is highly defensive, with a 288.0% current ratio, 66.6% equity ratio, ¥8.17bn of cash, and only ¥0.81bn of interest-bearing debt., FY2026 guidance progress is ahead of a standard first-half pace for operating income, at 65.4%, while forecast DPS of ¥105 implies a modest 25.0% payout ratio., The key offset to the positive first-half profile is the 96-day annualized DSO alert and associated need to improve cash collection..

Metrics to watch include Annualized DSO and the absolute movement in trade and electronic receivables, Second-half gross margin, operating margin, and SG&A growth relative to revenue, Operating cash flow and OCF/EBITDA cash conversion, Progress against ¥45.30bn revenue, ¥3.45bn operating income, and ¥3.50bn profit attributable to owners guidance, Investment-securities valuation changes, dividend income, and resulting OCI volatility, Finished-goods inventory trend and capital expenditure relative to depreciation, Execution of the ¥105 per-share ordinary dividend policy.

Regarding relative positioning, The company combines good, improving operating profitability with unusually strong liquidity and very low interest-bearing leverage. Its 9.6% operating margin and 8.0% net margin are within the stated good range, while annualized ROE of 7.9% remains modest relative to higher-return industrial peers. Balance-sheet resilience and dividend capacity are clear strengths; receivables efficiency and securities-market sensitivity are the principal factors that temper the otherwise favorable earnings and cash-flow profile.